Shenzhen - Delayed Quote CNY
Winning Health Technology Group Co., Ltd. (300253.SZ)
9.95
-0.48
(-4.61%)
As of 2:42:10 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,632,724.24
2,782,240.90
3,163,424.80
3,092,864.69
2,750,202.06
Cost of Revenue
1,521,614.78
1,622,614.59
1,740,882.29
1,741,612.56
1,475,529.29
Gross Profit
1,111,109.46
1,159,626.31
1,422,542.52
1,351,252.13
1,274,672.77
Operating Expense
633,468.49
682,282.86
864,034.35
910,057.55
727,587.07
Operating Income
477,640.97
477,343.45
558,508.17
441,194.58
547,085.69
Net Non Operating Interest Income Expense
-58,748.98
-57,441.15
-51,074.50
18,382.45
10,009.56
Pretax Income
88,672.21
86,959.33
340,747.20
38,540.80
373,168.14
Tax Provision
48,444.02
36,891.69
23,131.71
23,783.02
19,433.86
Net Income Common Stockholders
76,562.20
87,893.18
357,959.12
108,640.08
378,174.12
Basic EPS
0.04
--
0.17
0.05
0.18
Diluted EPS
0.04
--
0.16
0.05
0.18
Basic Average Shares
2,165,603.51
--
2,147,325.28
2,138,584.22
2,142,629.55
Diluted Average Shares
2,170,896.49
--
2,194,721.80
2,142,802.33
2,147,496.40
Total Operating Income as Reported
89,862.59
87,172.80
341,431.01
39,501.64
374,661.99
Rent Expense Supplemental
--
15,390.48
13,855.68
15,223.61
17,006.25
Total Expenses
2,155,083.27
2,304,897.45
2,604,916.63
2,651,670.11
2,203,116.37
Net Income from Continuing & Discontinued Operation
76,562.20
87,893.18
357,959.12
108,640.08
378,174.12
Normalized Income
252,781.72
303,605.25
510,372.21
330,904.31
470,935.57
Interest Income
8,860.84
10,140.08
13,590.81
20,616.84
11,798.84
Interest Expense
66,807.45
66,760.95
64,051.54
1,579.45
1,146.91
Net Interest Income
-58,748.98
-57,441.15
-51,074.50
18,382.45
10,009.56
EBIT
155,479.66
153,720.28
404,798.74
40,120.24
374,315.05
EBITDA
155,479.66
339,722.76
578,228.68
157,383.92
474,237.98
Reconciled Cost of Revenue
1,521,614.78
1,622,614.59
1,740,882.29
1,741,612.56
1,475,529.29
Reconciled Depreciation
--
186,002.49
173,429.94
117,263.68
99,922.92
Net Income from Continuing Operation Net Minority Interest
76,562.20
87,893.18
357,959.12
108,640.08
378,174.12
Total Unusual Items Excluding Goodwill
-293,699.20
-287,616.10
-163,513.23
-296,352.31
-97,857.69
Total Unusual Items
-293,699.20
-287,616.10
-163,513.23
-296,352.31
-97,857.69
Normalized EBITDA
449,178.86
627,338.87
741,741.91
453,736.24
572,095.67
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-117,479.68
-71,904.03
-11,100.14
-74,088.08
-5,096.23
12/31/2021 - 8/19/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4LL.SG Teladoc Health Inc
6.47
-1.28%
50V.F Aino Health AB (publ)
0.0005
-90.00%
4483.T JMDC Inc.
3,189.00
-1.88%
27R.F RaySearch Laboratories AB (publ)
28.55
+1.96%
GPI.MI GPI S.p.A.
9.82
-0.10%
ONE.AX Oneview Healthcare PLC
0.2700
-5.26%
RENX.L Renalytix Plc
8.25
0.00%
4LL.F Teladoc Health, Inc.
6.62
-0.45%
CRW.L Craneware plc
1,970.00
+1.55%
FOXOW FOXO Technologies Inc. Redeemab
0.0250
+115.52%